TH

Thalassa Holdings Ltd.

A holding company active in property rentals and marine seismic & defense R&D.

THAL | IL

Overview

Corporate Details

ISIN(s):
VGG878801114
LEI:
2138002739WFQPLBEQ42
Country:
Virgin Islands (British)
Address:
FOLIO CHAMBERS, VG1110 ROAD TOWN
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Thalassa Holdings Ltd. is a holding company engaged in international business activities. The company's operations are primarily focused on two segments: Rental Income, derived from its property interests, and Product Development. The Product Development segment concentrates on marine seismic and defense research and development, including geophysical project management, related services, and the supply of equipment. The company's strategic goal is to generate long-term shareholder value by deploying capital and expertise into investment opportunities.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-29 11:39
M&A Activity
Thalassa Holdings Ltd: Trading Update
English 9.9 KB
2025-10-29 11:39
M&A Activity
Thalassa Holdings Ltd: Trading Update
English 11.4 KB
2025-10-15 09:35
Board/Management Information
Thalassa Holdings Ltd: Thalassa Board reaches agreement with Newmark Security p…
English 9.1 KB
2025-10-15 09:35
Board/Management Information
Thalassa Holdings Ltd: Thalassa Board reaches agreement with Newmark Security p…
English 10.5 KB
2025-10-08 08:30
Regulatory News Service
Thalassa Holdings Ltd: Letter to Newmark Security plc (NWT) Shareholders
English 562.7 KB
2025-10-08 08:30
Major Shareholding Notification
Thalassa Holdings Ltd: Letter to Newmark Security plc (NWT) Shareholders
English 722.8 KB
2025-09-29 10:57
Board/Management Information
Thalassa Holdings Ltd: Surgical Innovations Group plc
English 7.9 KB
2025-09-29 08:30
Interim Report
Thalassa Holdings Ltd: 2025 Interim Results
English 408.7 KB
2025-09-29 08:30
Earnings Release
Thalassa Holdings Ltd: 2025 Interim Results
English 496.5 KB

Automate Your Workflow. Get a real-time feed of all Thalassa Holdings Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Thalassa Holdings Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Thalassa Holdings Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

OSCOTECInc. Logo
A clinical-stage drug discovery company developing innovative medicines for unmet needs.
South Korea
039200
OSE Immunotherapeutics Logo
Develops first-in-class immune therapies for oncology and inflammation, partnering for late-stage.
France
OSE
Oxurion NV Logo
Acquires European pharmaceutical subcontractors to build an integrated healthcare services group.
Belgium
OXUR
PA Co., Ltd Logo
Offers HR solutions like recruitment media, staffing, and childcare to revitalize local communities.
Japan
4766
Passage BIO, Inc. Logo
Developing genetic medicines for severe CNS and neurodegenerative disorders.
United States of America
PASG
PCI Biotech Holding Logo
Biopharma firm evaluating its future after discontinuing its core technology development.
Norway
PCIB
PC İLETİŞİM VE MEDYA HİZMETLERİ SANAYİ TİCARET A.Ş. Logo
Integrated media group providing data-driven advertising and media solutions for global brands.
Türkiye
PCILT
PDS Biotechnology Corp Logo
Developing T-cell activating immunotherapies for cancer and infectious diseases.
United States of America
PDSB
Peers Co.,Ltd. Logo
Accelerating tech adoption with consulting, HR services, and proprietary IT/AI solutions.
Japan
7066
PepGen Inc. Logo
Biotech using an EDO platform to treat genetic neuromuscular & neurological diseases.
United States of America
PEPG

Talk to a Data Expert

Have a question? We'll get back to you promptly.